Has decellularized porcine cornea been used in humans for cornea treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Decellularized Porcine Corneas Have Been Successfully Used in Human Corneal Transplantation

Yes, decellularized porcine corneas have been successfully used in humans for corneal treatment, specifically as anterior lamellar keratoplasty grafts to treat corneal ulcers in patients in China. 1

Current Status of Porcine Corneal Xenotransplantation in Humans

The use of decellularized porcine corneas represents a significant advancement in addressing the global shortage of human corneal tissue for transplantation. According to the International Journal of Surgery, a Chinese research group has achieved encouraging clinical results using decellularized porcine corneas as anterior lamellar keratoplasty (ALK) grafts to treat corneal ulcers in human patients 1.

Advantages of Decellularized Porcine Corneas

Decellularization offers several important benefits for xenotransplantation:

  • Reduced immunogenicity: Removal of cellular components significantly reduces the immune response compared to fresh corneas 1
  • Preservation of extracellular matrix structure: The decellularization process can maintain the essential collagen architecture needed for corneal function 2
  • Abundant supply: Porcine corneas could help solve the worldwide shortage of donor corneal tissue

Decellularization Methods

Multiple techniques have been developed to decellularize porcine corneas, though no standardized protocol has yet been established 3. The most common methods include:

  • Hypertonic saline-based decellularization: Shown to maintain intact collagen structures while removing cellular components 2
  • Chemical methods: Using agents like sodium dodecyl sulfate (SDS), triton X-100, or EDTA 4
  • Physical methods: Including freeze-thaw cycles, high hydrostatic pressure, or nitrogen gas 3
  • Combined approaches: Often more effective than single methods alone 3

The hypertonic saline method has demonstrated particularly promising results, with xenografts remaining clear in animal models for over 6 months 2.

Clinical Applications and Outcomes

The clinical use of decellularized porcine corneas has primarily focused on anterior lamellar keratoplasty, where only the front portion of the cornea is replaced. This approach is particularly suitable for treating:

  • Corneal ulcers
  • Anterior stromal opacities
  • Certain types of corneal dystrophies

The biophysical properties of porcine corneas make them suitable alternatives to human tissue:

  • Corneal power: Porcine corneas (40D) are slightly flatter than human corneas (44D), but within a tolerable range for transplantation 1
  • Tensile strength: Similar to human corneas, though with some differences in stress-relaxation and stiffness 1

Future Perspectives

The field of corneal xenotransplantation continues to evolve with several promising approaches:

  1. Further refinement of decellularization techniques: To optimize the balance between complete cell removal and preservation of corneal architecture 3

  2. Recellularization with human cells: Some research explores repopulating decellularized porcine corneas with human corneal cells to create hybrid grafts 4, 5

  3. Genetically engineered pigs: Development of GTKO/CD46/CIITA-DN pigs could further reduce human immune responses 1

Potential Limitations and Considerations

Despite promising results, several challenges remain:

  • Potential for corneal haze or scarring: Post-transplant complications have been observed in some cases 5
  • Variability in outcomes: Results may depend on specific decellularization protocols and patient factors
  • Long-term durability: More extended follow-up studies are needed to assess long-term outcomes

With continued advances in immunosuppressive protocols, decellularized porcine corneas represent a realistic option for addressing the global shortage of corneal tissue for transplantation 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.